Literature DB >> 18403602

Matrix metalloproteinase 12 accelerates the initiation of atherosclerosis and stimulates the progression of fatty streaks to fibrous plaques in transgenic rabbits.

Sohsuke Yamada1, Ke-Yong Wang, Akihide Tanimoto, Jianglin Fan, Shohei Shimajiri, Shuji Kitajima, Masatoshi Morimoto, Masato Tsutsui, Teruo Watanabe, Kosei Yasumoto, Yasuyuki Sasaguri.   

Abstract

Whether fatty streaks are directly followed by fibrous plaque formation in atherosclerosis remains controversial. Disruption of the basement membrane and elastic layers is thought to be essential for this process. Matrix metalloproteinase 12 (MMP-12) can degrade a broad spectrum of substrates, but the role of MMP-12 in the early stage of atherosclerosis is unclear. To investigate MMP-12 function in the initiation and progression of atherosclerosis, we investigated macrophage migration and elastolysis in relation to fatty streaks in human MMP-12 transgenic (hMMP-12 Tg) rabbits. Fatty streaks in hMMP-12 Tg rabbits fed a 1% cholesterol diet for 6 weeks (cholesterol-induced model of atherosclerosis) were more pronounced and were associated with more significant degradation of the internal elastic layer compared with wild-type (WT) animals. Numbers of infiltrating macrophages and smooth muscle cells in the lesions were increased in hMMP-12 Tg compared with WT animals. In both cuff- and ligation-induced models of atherosclerosis, smooth muscle cell-predominant atherosclerotic lesions were elevated with significant elastolysis of the internal elastic lamina in Tg compared with WT animals; "microelastolytic sites" were recognized before formation of the neointima in the cuff model only. These results indicate that MMP-12 may be critical to the initiation and progression of atherosclerosis via degradation of the elastic layers and/or basement membrane. Therefore, a specific MMP-12 inhibitor might prove useful for the treatment of progressive atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18403602      PMCID: PMC2329850          DOI: 10.2353/ajpath.2008.070604

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration.

Authors:  Susan M Majka; Kathyjo A Jackson; Kirsten A Kienstra; Mark W Majesky; Margaret A Goodell; Karen K Hirschi
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

2.  Adult cardiac stem cells are multipotent and support myocardial regeneration.

Authors:  Antonio P Beltrami; Laura Barlucchi; Daniele Torella; Mathue Baker; Federica Limana; Stefano Chimenti; Hideko Kasahara; Marcello Rota; Ezio Musso; Konrad Urbanek; Annarosa Leri; Jan Kajstura; Bernardo Nadal-Ginard; Piero Anversa
Journal:  Cell       Date:  2003-09-19       Impact factor: 41.582

3.  Induction of human matrix metalloproteinase-12 gene transcriptional activity by GM-CSF requires the AP-1 binding site in human U937 monocytic cells.

Authors:  L Wu; A Tanimoto; Y Murata; J Fan; Y Sasaguri; T Watanabe
Journal:  Biochem Biophys Res Commun       Date:  2001-07-13       Impact factor: 3.575

4.  Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease.

Authors:  S Jormsjö; S Ye; J Moritz; D H Walter; S Dimmeler; A M Zeiher; A Henney; A Hamsten; P Eriksson
Journal:  Circ Res       Date:  2000-05-12       Impact factor: 17.367

5.  Matrix metalloproteinase-12 gene expression in human vascular smooth muscle cells.

Authors:  Lihua Wu; Akihide Tanimoto; Yoshitaka Murata; Takakazu Sasaguri; Jianglin Fan; Yasuyuki Sasaguri; Teruo Watanabe
Journal:  Genes Cells       Date:  2003-03       Impact factor: 1.891

6.  Induction and regulation of matrix metalloproteinase-12 by cytokines and CD40 signaling in monocyte/macrophages.

Authors:  L Wu; J Fan; S i Matsumoto; T Watanabe
Journal:  Biochem Biophys Res Commun       Date:  2000-03-24       Impact factor: 3.575

7.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.

Authors:  Masataka Sata; Akio Saiura; Atsushi Kunisato; Akihiro Tojo; Seiji Okada; Takeshi Tokuhisa; Hisamaru Hirai; Masatoshi Makuuchi; Yasunobu Hirata; Ryozo Nagai
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

8.  Macrophage-specific overexpression of human matrix metalloproteinase-12 in transgenic rabbits.

Authors:  Jianglin Fan; Xiaofei Wang; Lihua Wu; Shin-Ich Matsumoto; Jingyan Liang; Tomonari Koike; Tomonaga Ichikawa; Huijun Sun; Hisataka Shikama; Yasuyuki Sasaguri; Teruo Watanabe
Journal:  Transgenic Res       Date:  2004-06       Impact factor: 2.788

9.  Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages.

Authors:  S D Shapiro; D K Kobayashi; T J Ley
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

10.  Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice.

Authors:  Yanhua Hu; Zhongyi Zhang; Evelyn Torsney; Ali R Afzal; Fergus Davison; Bernhard Metzler; Qingbo Xu
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

View more
  44 in total

Review 1.  The role of matrix metalloproteinases in atherothrombosis.

Authors:  Daniel F J Ketelhuth; Magnus Bäck
Journal:  Curr Atheroscler Rep       Date:  2011-04       Impact factor: 5.113

Review 2.  Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases.

Authors:  Takayuki Shiomi; Vincent Lemaître; Jeanine D'Armiento; Yasunori Okada
Journal:  Pathol Int       Date:  2010-07       Impact factor: 2.534

Review 3.  MMP-12, a Promising Therapeutic Target for Neurological Diseases.

Authors:  Bharath Chelluboina; Koteswara Rao Nalamolu; Jeffrey D Klopfenstein; David M Pinson; David Z Wang; Raghu Vemuganti; Krishna Kumar Veeravalli
Journal:  Mol Neurobiol       Date:  2017-02-02       Impact factor: 5.590

4.  MMP-12, a novel matrix metalloproteinase associated with giant cell arteritis.

Authors:  Alicia Rodríguez-Pla; Francisco Martínez-Murillo; Peter J Savino; Ralph C Eagle; Philip Seo; Mark J Soloski
Journal:  Rheumatology (Oxford)       Date:  2009-09-06       Impact factor: 7.580

5.  Matrix metalloproteinase 12-deficiency augments extracellular matrix degrading metalloproteinases and attenuates IL-13-dependent fibrosis.

Authors:  Satish K Madala; John T Pesce; Thirumalai R Ramalingam; Mark S Wilson; Samantha Minnicozzi; Allen W Cheever; Robert W Thompson; Margaret M Mentink-Kane; Thomas A Wynn
Journal:  J Immunol       Date:  2010-02-24       Impact factor: 5.422

6.  Radiolabelled probes for imaging of atherosclerotic plaques.

Authors:  Takashi Temma; Hideo Saji
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-10-15

7.  Outside-in signaling by femoral cuff injury induces a distinct vascular lesion in adipose triglyceride lipase knockout mice.

Authors:  Hirotsugu Noguchi; Sohsuke Yamada; Ken-Ichi Hirano; Satoshi Yamaguchi; Akira Suzuki; Xin Guo; Nobuhiro Zaima; Ming Li; Kunihisa Kobayashi; Yoshihiko Ikeda; Toshiyuki Nakayama; Yasuyuki Sasaguri
Journal:  Histol Histopathol       Date:  2020-11-24       Impact factor: 2.303

Review 8.  Rabbit models for the study of human atherosclerosis: from pathophysiological mechanisms to translational medicine.

Authors:  Jianglin Fan; Shuji Kitajima; Teruo Watanabe; Jie Xu; Jifeng Zhang; Enqi Liu; Y Eugene Chen
Journal:  Pharmacol Ther       Date:  2014-09-30       Impact factor: 12.310

9.  Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life.

Authors:  Roya Kelishadi
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

Review 10.  Omics-based approaches to understand mechanosensitive endothelial biology and atherosclerosis.

Authors:  Rachel D Simmons; Sandeep Kumar; Salim Raid Thabet; Sanjoli Sur; Hanjoong Jo
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.